Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
Clinical trial NCT01210001 · COMPLETED
Trial details
- NCT number
- NCT01210001
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.